Clinical Cancer Research The Future of Cancer Research: Science and Patient Impact Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baekelandt, M.
Right arrow Articles by Kristensen, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baekelandt, M.
Right arrow Articles by Kristensen, G. B.
Clinical Cancer Research Vol. 5, 2848-2853, October 1999
© 1999 American Association for Cancer Research


Molecular Oncology, Markers, Clinical Correlates

Lack of Independent Prognostic Significance of p21 and p27 Expression in Advanced Ovarian Cancer: An Immunohistochemical Study1

Mark Baekelandt2, Ruth Holm, Claes G. Tropé, Jahn M. Nesland and Gunnar B. Kristensen

Departments of Gynecologic Oncology [M. B., C. G. T., G. B. K.] and Pathology [R. H., J. M. N.], The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway

The eukaryotic cell cycle is controlled by protein complexes consisting of cyclin-dependent kinases and cyclins. The cyclin-dependent kinases are in turn negatively regulated by a family of cyclin-dependent kinase inhibitors, comprising, among others, the p21 and p27 proteins. p21 and p27 have been shown to be of prognostic significance in a broad array of human tumors. Using immunohistochemistry, the frequency of expression and the possible prognostic and predictive significance of these proteins were examined in a series of 185 uniformly treated patients with stage III ovarian cancer. We found p21 to be overexpressed in 48% of cases. No significant correlation was found between the expression of p21 and p53 proteins (P = 0.273). A low level of p27 was demonstrated in 48.5% of cases. p21 overexpression correlated with lower Fédération Internationale des Gynaecologistes et Obstetristes substage, lower patient age, and absence of ascites, but neither p21 nor p27 expression was of prognostic significance for the whole group of patients. Only a trend toward reduced survival (P = 0.092) was noticed for the small subgroup of patients (6%), whose tumors lacked p27 expression completely. A clear positive correlation could be found between p21 and p27 protein expression (P = 0.012). Despite the suggested role of the 21 and p27 proteins in determining drug sensitivity, they were not found to be predictive for response to chemotherapy, as assessed by second-look laparotomy in this large group of patients with advanced ovarian cancer.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. Psyrri, A. Bamias, Z. Yu, P. M. Weinberger, M. Kassar, S. Markakis, D. Kowalski, E. Efstathiou, R. L. Camp, D. L. Rimm, et al.
Subcellular Localization and Protein Levels of Cyclin-Dependent Kinase Inhibitor p27 Independently Predict for Survival in Epithelial Ovarian Cancer
Clin. Cancer Res., December 1, 2005; 11(23): 8384 - 8390.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. G. Rosen, G. Yang, K. Q. Cai, R. C. Bast Jr., D. M. Gershenson, E. G. Silva, and J. Liu
Subcellular Localization of p27kip1 Expression Predicts Poor Prognosis in Human Ovarian Cancer
Clin. Cancer Res., January 15, 2005; 11(2): 632 - 637.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. D'Andrilli, C. Kumar, G. Scambia, and A. Giordano
Cell Cycle Genes in Ovarian Cancer: Steps Toward Earlier Diagnosis and Novel Therapies
Clin. Cancer Res., December 15, 2004; 10(24): 8132 - 8141.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Bali, P. M. O'Brien, L. S. Edwards, R. L. Sutherland, N. F. Hacker, and S. M. Henshall
Cyclin D1, p53, and p21Waf1/Cip1 Expression Is Predictive of Poor Clinical Outcome in Serous Epithelial Ovarian Cancer
Clin. Cancer Res., August 1, 2004; 10(15): 5168 - 5177.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Plisiecka-Halasa, G. Karpinska, T. Szymanska, I. Ziolkowska, R. Madry, A. Timorek, J. Debniak, M. Ulanska, M. Jedryka, A. Chudecka-Glaz, et al.
P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens
Ann. Onc., July 1, 2003; 14(7): 1078 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. L. Rose, M. J. Goodheart, B. R. DeYoung, B. J. Smith, and R. E. Buller
p21 Expression Predicts Outcome in p53-null Ovarian Carcinoma
Clin. Cancer Res., March 1, 2003; 9(3): 1028 - 1032.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Masciullo, G. Ferrandina, B. Pucci, F. Fanfani, S. Lovergine, J. Palazzo, G. Zannoni, S. Mancuso, G. Scambia, and A. Giordano
p27Kip1 Expression Is Associated with Clinical Outcome in Advanced Epithelial Ovarian Cancer: Multivariate Analysis
Clin. Cancer Res., December 1, 2000; 6(12): 4816 - 4822.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.